West Pharmaceutical Services Inc (WST) stock
WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3032% above fair value
$416.42+5.12 (+1.24%)
Close on Nov 13, 2026Market cap $29.01BP/E 46.7Yield 0.21%
West Pharmaceutical Services gross margin
Gross margin is gross profit as a percentage of revenue.
West Pharmaceutical Services's gross margin for the twelve months ending Sep 30, 2026 was 37.6%. For fiscal 2025 it was 35.9%, against 34.5% the year before. The highest annual figure on record is 41.5% in fiscal 2021.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 35.9% | +1.4 |
| FY2024 | Dec 31, 2024 | 34.5% | −3.8 |
| FY2023 | Dec 31, 2023 | 38.3% | −1.1 |
| FY2022 | Dec 31, 2022 | 39.4% | −2.2 |
| FY2021 | Dec 31, 2021 | 41.5% | +5.8 |
| FY2020 | Dec 31, 2020 | 35.8% | +2.8 |
| FY2019 | Dec 31, 2019 | 32.9% | +1.2 |
| FY2018 | Dec 31, 2018 | 31.8% | −0.3 |
| FY2017 | Dec 31, 2017 | 32.1% | −1.2 |
| FY2016 | Dec 31, 2016 | 33.2% | +0.7 |
| FY2015 | Dec 31, 2015 | 32.6% | +1.1 |
| FY2014 | Dec 31, 2014 | 31.5% | −0.3 |
| FY2013 | Dec 31, 2013 | 31.8% | +1.2 |
| FY2012 | Dec 31, 2012 | 30.6% | +2.2 |
| FY2011 | Dec 31, 2011 | 28.5% | −0.3 |
| FY2010 | Dec 31, 2010 | 28.8% | +0.0 |
| FY2009 | Dec 31, 2009 | 28.8% | −0.0 |
| FY2008 | Dec 31, 2008 | 28.8% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 39.7% | +3.1 |
| Q2 FY2026 | Jun 30, 2026 | 37.7% | +2.0 |
| Q1 FY2026 | Mar 31, 2026 | 35.1% | +1.9 |
| Q4 FY2025 | Dec 31, 2025 | 37.8% | +1.2 |
| Q3 FY2025 | Sep 30, 2025 | 36.6% | +1.1 |
| Q2 FY2025 | Jun 30, 2025 | 35.7% | +3.0 |
| Q1 FY2025 | Mar 31, 2025 | 33.2% | +0.1 |
| Q4 FY2024 | Dec 31, 2024 | 36.5% | −1.5 |
| Q3 FY2024 | Sep 30, 2024 | 35.4% | −3.1 |
| Q2 FY2024 | Jun 30, 2024 | 32.8% | −5.9 |
| Q1 FY2024 | Mar 31, 2024 | 33.1% | −4.8 |
| Q4 FY2023 | Dec 31, 2023 | 38.0% | +1.0 |
| Q3 FY2023 | Sep 30, 2023 | 38.6% | −0.4 |
| Q2 FY2023 | Jun 30, 2023 | 38.7% | −3.0 |
| Q1 FY2023 | Mar 31, 2023 | 37.9% | −1.7 |
| Q4 FY2022 | Dec 31, 2022 | 37.0% | −4.1 |
| Q3 FY2022 | Sep 30, 2022 | 39.0% | −1.8 |
| Q2 FY2022 | Jun 30, 2022 | 41.7% | −1.9 |
| Q1 FY2022 | Mar 31, 2022 | 39.5% | −1.0 |
| Q4 FY2021 | Dec 31, 2021 | 41.1% | +4.7 |
| Q3 FY2021 | Sep 30, 2021 | 40.8% | +5.3 |
| Q2 FY2021 | Jun 30, 2021 | 43.5% | +6.5 |
| Q1 FY2021 | Mar 31, 2021 | 40.5% | +6.6 |
| Q4 FY2020 | Dec 31, 2020 | 36.4% | +3.8 |
| Q3 FY2020 | Sep 30, 2020 | 35.5% | +3.1 |
| Q2 FY2020 | Jun 30, 2020 | 37.0% | +3.4 |
| Q1 FY2020 | Mar 31, 2020 | 34.0% | +0.9 |
| Q4 FY2019 | Dec 31, 2019 | 32.6% | +1.0 |
| Q3 FY2019 | Sep 30, 2019 | 32.4% | +1.0 |
| Q2 FY2019 | Jun 30, 2019 | 33.6% | +1.8 |
| Q1 FY2019 | Mar 31, 2019 | 33.1% | +0.8 |
| Q4 FY2018 | Dec 31, 2018 | 31.5% | +0.6 |
| Q3 FY2018 | Sep 30, 2018 | 31.4% | −0.0 |
| Q2 FY2018 | Jun 30, 2018 | 31.8% | +0.3 |
| Q1 FY2018 | Mar 31, 2018 | 32.3% | −2.3 |
| Q4 FY2017 | Dec 31, 2017 | 30.9% | −1.4 |
| Q3 FY2017 | Sep 30, 2017 | 31.4% | – |
| Q2 FY2017 | Jun 30, 2017 | 31.4% | – |
| Q1 FY2017 | Mar 31, 2017 | 34.6% | – |
| Q4 FY2016 | Dec 31, 2016 | 32.4% | – |
See a number that looks wrong?